van der Heijde, D., Dijkmans, B., Schiff, M., Kivitz, A., de Vlam, K., Wordsworth, P., . . . Grp, A. (2008). Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS).
Chicago-referens (17:e uppl.)van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.
MLA-referens (9:e uppl.)van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.